The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia.

Details

Serval ID
serval:BIB_DBECCA1A0EFD
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia.
Journal
Clinical infectious diseases
Author(s)
François B., Chastre J., Eggiman P., Laterre P.F., Torres A., Sanchez M., Esser M.T., Bishop B., Bonten M., Goosens H., Jafri H.S.
ISSN
1537-6591 (Electronic)
ISSN-L
1058-4838
Publication state
Published
Issued date
15/08/2016
Peer-reviewed
Oui
Volume
63 Suppl 2
Pages
S46-51
Language
english
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Abstract
The Innovative Medicines Initiative-funded COMBACTE consortium fosters academic-industry partnership in pioneering studies to combat serious bacterial infections. We describe how this partnership is advancing the development of 2 monoclonal antibodies, MEDI4893 and MEDI3902, for the prevention of nosocomial pneumonia.

Keywords
Anti-Bacterial Agents/therapeutic use, Antibodies, Monoclonal/therapeutic use, Cross Infection/prevention & control, Drug Discovery, Humans, Pneumonia, Bacterial/prevention & control, Pneumonia, Ventilator-Associated/prevention & control, Public-Private Sector Partnerships, United States, ICU, monoclonal antibody, nosocomial pneumonia, ventilator-associated pneumonia
Pubmed
Web of science
Open Access
Yes
Create date
04/08/2016 17:57
Last modification date
21/08/2019 6:36
Usage data